Avantor reports first quarter 2020 resultsLearn more
Industries we serve
Avantor works with ambitious clients in a broad range of industries, using deep knowledge and a collaborative approach to create and deliver innovative products and solutions across them all.
Opportunities and challenges in cell and gene therapy development
Q&A interview with Ger Brophy, Avantor’s Executive Vice President, Biopharma Production
A Fresh Look Inside Avantor’s Bridgewater Innovation Center
In 2017, the Bridgewater Innovation Center was opened as a technology-driven research and collaboration environment where Avantor experts work closely with customers to solve science’s most difficult challenges.
Avantor serves our global customers with a proven portfolio of trusted, quality brands, as well as products from thousands of other manufacturers.
Processing times can be reduced and yields increased by utilizing new hydrophobic interaction chromatography tools.
A global pharmaceutical company sought new ways to help senior scientists focus more time and attention on innovation and strategic drug project work.
A medical device OEM needed a fast cure silicone adhesive to boost throughout to maximize efficiencies.
News & events
Learn how we support and enable the industries we serve.
Fitch upgrades the company's long-term issuer default rating to BB-/Stable...
Avantor, Inc., today announced the pricing of the previously announced underwritten secondary offering of 45,000,000 shares of the Company's common stock...
Avantor, Inc., today announced that certain of its stockholders (the "Selling Stockholders") intend to offer for sale in an underwritten secondary offering 45,000,000 shares of common stock...
The Avantor Foundation donates $100K to Charities Aid Foundation of America (CAF America) to support hospitals and relief organizations globally...